ERBB2 and breast carcinoma: Caceres et al. 2015 [9] established the first canine inflammatory mammary carcinoma cell line, named IPC-366, with an epithelial phenotype and the triple-negative expressions of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2).